Skip to content
Hombrio

Myths and facts about GLP-1

What people say about these medicines and what the labels and studies show, with sources.

Does alcohol change anything?

What people say: On these medicines, drinking is the same as always.

Myth

Not quite. Alcohol can make nausea and reflux worse, and the guidance is to keep it to a minimum. Drinking a lot is one of the most common causes of pancreatitis; strong belly pain that doesn't go away is in Help, under when to get care. If you use insulin or a sulfonylurea, drinking a lot, especially without food, can bring on low blood sugar. Some users say they drink less on these medicines, and small studies are looking at this, but they aren't an approved treatment for drinking problems.

Sources

  1. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity 2025;33(8):1475-1503.
  2. NHS. Acute pancreatitis (page reviewed 11/03/2026).
  3. NHS. Low blood sugar (hypoglycaemia) (page reviewed 03/08/2023).
  4. Plenn E et al. A Qualitative Analysis of Patient Experiences Using Semaglutide 2.4 mg for Weight Loss. Obes Sci Pract 2025;11(4):e70085.
  5. Klausen MK et al. Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity (SEMALCO). Lancet 2026.

Should strength training wait?

What people say: I'll start lifting weights after I've lost the weight.

Myth

Guidelines recommend strength training while you lose weight, not after: two to three times a week or more. In a Danish trial with liraglutide, people on the medicine alone lost more bone density at the hip and spine than those who exercised, and their fitness didn't improve, while it did in the exercise groups. You can start light, at level 1, and build from there.

Sources

  1. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity 2025;33(8):1475-1503.
  2. ABESO. Diretriz Brasileira de Tratamento Farmacológico da Obesidade 2026 (PDF, 20/03/2026).
  3. Jensen SBK et al. Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: a secondary analysis of a randomized clinical trial (S-LiTE). JAMA Netw Open 2024;7(6):e2416775.
  4. Jensen SBK et al. Sports Med 2026 (S-LiTE trial: physical fitness and muscle strength, secondary analysis).

Is regain after stopping your fault?

What people say: If the weight comes back after I stop, it's my fault.

Myth

It's physiology, not weakness. In a 2026 review, about two thirds of the weight lost with semaglutide or tirzepatide came back within a year of stopping, on average. Staying active and keeping your habits is the best bet we know of, with no guarantee. The decision to stop is one to make with your doctor.

Sources

  1. West S et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ 2026;392:e085304.
  2. Jensen SBK et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial (S-LiTE). eClinicalMedicine 2024;69:102475 (full text checked on PMC).
  3. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity 2025;33(8):1475-1503.

Is more protein always better?

What people say: When it comes to protein, the more the better.

Myth

Not quite. Guidelines for people on these medicines give a range, not a single number, and there's no agreement on which body weight to base it on. They also advise against staying at very high intakes for a long time. With kidney disease, the advice is lower, not higher. Your target is yours, or your doctor's or dietitian's, and the guideline reference is in the Strength tab.

Sources

  1. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity 2025;33(8):1475-1503.
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD). Kidney Int 2024;105(4S).

Do results with medication count?

What people say: Losing weight with medication doesn't really count.

Myth

It counts. Brazil's 2026 obesity medication guideline describes obesity as a chronic disease and recommends medication together with lifestyle changes. And the medicine doesn't do all the work: in one trial, exercise plus the medicine kept the weight off better than either one alone; in a small six-week study with men, training built strength and the medicine added nothing to it. The training, the protein and the routine are yours. That's physiology, not weakness.

Sources

  1. ABESO. Diretriz Brasileira de Tratamento Farmacológico da Obesidade 2026 (PDF, 20/03/2026).
  2. Lundgren JR et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined (S-LiTE). N Engl J Med 2021;384(18):1719-1730.
  3. Bagherzadeh-Rahmani B et al. Clin Hemorheol Microcirc 2024 (tirzepatide with exercise training in men with obesity and prediabetes, 6-week randomized trial).

No nausea, no effect?

What people say: If I don't feel sick, the medication isn't working.

Myth

Feeling sick isn't a sign that it's working. In the semaglutide trials, stomach symptoms explained only a tiny part of the weight loss, and nausea doesn't predict who loses more. In some studies, men also reported nausea less often than women. How you feel is worth noting for your next appointment, nausea or not.

Sources

  1. Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity. Diabetes Obes Metab 2022;24:94-105.
  2. Alhazmi A, le Roux CW. Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. Front Endocrinol 2026;17:1788698 (opinion article).
  3. Petri KCC et al. Diabetes Obes Metab 2018 (exposure-response analysis of the SUSTAIN trials).
  4. Lean MEJ et al. Int J Obes 2014 (phase 2 randomized trial of liraglutide for weight management).

Can you skip meals when you aren't hungry?

What people say: If I'm not hungry, I can skip meals and eat once at night.

Myth

Eating less is expected with these medicines. Skipping meals and then eating one big one is different: the guidance is small meals at regular times, with protein, and vomiting is more likely after large meals. When hunger is low, a small portion with protein already counts. The low-appetite recipes have ideas.

Sources

  1. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity 2025;33(8):1475-1503.

Is protein enough to keep muscle?

What people say: If I eat enough protein, I don't need to train to keep my muscle.

Myth

Protein helps, but on its own it's probably not enough. Part of the weight lost is lean mass, which includes muscle, and guidelines pair protein at every meal with strength training. In a study of weight loss by eating less, without an exercise program, men were estimated to lose close to twice as much muscle as women for each kilo lost. Strength and protein work as a pair.

Sources

  1. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity 2025;33(8):1475-1503.
  2. Look M et al. Body composition changes during weight reduction with tirzepatide in SURMOUNT-1. Diabetes Obes Metab 2025;27:2720-2729.
  3. Heymsfield SB et al. Proportion of caloric restriction-induced weight loss as skeletal muscle. Obesity 2024;32:32-40.
Open in the app

Free, no account and nothing to install.